UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 83.30
+0.20 (0.24%)
May 8, 2026, 1:30 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 5.3 billion as of May 8, 2026. Its market cap has increased by 32.51% in one year.
Market Cap
5.30B
Enterprise Value
4.62B
Revenue
30.10M
Ranking
n/a
PE Ratio
n/a
Stock Price
83.30
Market Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 5.30B, an increase of 206.78%. That is a compound annual growth rate of 23.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.30B | -2.50% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 5.92B |
| Sinphar Pharmaceutical | 5.83B |
| Savior Lifetec | 5.82B |
| AnnJi Pharmaceutical | 5.70B |
| Panion & Bf Biotech | 5.52B |
| Steminent Biotherapeutics | 5.00B |
| Medigen Biotechnology | 4.60B |
| Senhwa Biosciences | 4.59B |